Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DI
Treatment
Specifics
dDAVP*
Free
Water
Replacement
Dose:
0.5-1.0
microgram
iv/sc/im
x
1**
1)
Evaluate
urine
OUT
volume,
serum
Osm,
urine
Osm
(either
q2h
or
q4h)
-
duration
of
action
8-12h,
rapidly
reduces
2)
Free
water
loss
=
UVol
(Uosm/POsm)xUVol
e.g.
UO,
no
BP
effect
1000ml
(160mOsm/320mOsm)x1000=
500ml
Always
consult
with
fellow
and/or
attending
3)
Replace
free
water
IV
(D5W)
or
PFT/NG
(water)
over
the
same
time
before
ordering.
interval
(either
2
or
4hours)
(oral
or
nasal
dDAVP
is
variably
absorbed
and
e.g.
500ml
free
water
=
D5W
at
250ml/h
for
2
hours
should
not
be
used
in
hospitalized
patients)
n.b.:
Most
ICU
patients
should
have
IV
water
replacement
dDAVP:
give
subsequent
dDAVP
doses
ONLY
if
urine
OUT
again
meets
polyuria
criteria
(see
above)
and
labs
again
meet
DI
diagnostic
criteria
(see
above)
Free
water:
In
general,
to
avoid
hyponatremia**
free
water
replacement
should
be
reduced
or
discontinued
if
dDAVP
treatment
is
initiated.
If
plasma
Osm
<310
mOsm/kg
free
water
replacement
should
absolutely
be
discontinued.
Monitor:
urine
OUT
(q1-4h),
plasma
Na+
and
K+,
urine
Na+
and
osmolality
q4hours
x24h
*dDAVP
should
be
considered
for
patients
with
DI
to:
1. Prevent
complications
related
to
massive
(IV
or
enteral)
free
water
replacement
(especially
in
ICU
patients
this
may
include
hyperglycemia,
neuronal
injury,
IV
access
problems),
2. To
prevent
washout
of
the
renal
medulla
which
secondarily
impairs
renal
urinary
concentrating
ability
**Patient
harm
from
hyponatremia
related
to
dDAVP
therapy
occurs
in
the
following
situations:
1. Wrong
diagnosis,
2. Scheduled
doses
of
dDAVP
when
DI
resolves
or
when
patient
transitions
to
the
second
phase
of
pituitary
stalk
injury
(uncontrolled
ADH
release
from
damaged
neurons),
3. Excess
IV
fluid
administration
OR
po
fluid
intake
(includes
all
liquids
i.e.
NS,
tube
feeds,
etc.
that
are
hypo-osmotic
compared
to
the
URINE
Osm
after
dDAVP
Rx)
Acute
Polyuria
Diagnosis
and
Workup
3
3)
For
patients
with
increased
ICP,
hypotension,
hypovolemia,
shock
or
severe
polytrauma:
(1) Resuscitate
to
normovolemia
using
isotonic
crystalloid
(Plasma-Lyte
or
normal
saline
[NOT
lactated
Ringers]).
(2) For
ongoing
polyuria
with
urine
output
>
500
ml/hour,
start
IV
vasopressin:
shorter
duration
of
action
than
dDAVP,
titratable,
simultaneously
treats
DI
and
hypotension
(a) Dose:
Start
at
0.04
units/minute
and
titrate
by
0.01
units/minute
every
hour
to
maintain
urine
output
<
500
ml/hour,
serum
Na+
140-145
meq/L
(max
rate
0.10
units
per
minute)
(b) Adjust
IV/FT
free
water
replacement
based
on
serial
monitoring
of
UOsm/POsm
and
UO
as
shown
above.
Acute
Polyuria
Diagnosis
and
Workup
4
Differential Diagnosis of Other Causes of Polyuria
Diagnosis
Lab
values
Additional
factors
Serum
Na+
low
Serum
Osm
high
Urine
Osm
low,
BUT
Osmotic
diuresis
Mannitol,
glucose,
contrast
dye
Urine
SG
high
Serum
and
urine
glucose
high
Serum
Na+
variable
Post-operative
or
post- Serum
Osm
normal
Check
Medic
One,
ED,
OR
Records
resuscitation
diuresis
Urine
Osm
Serum
Osm
Serum
Na+
&
Osm
History
(recent
AKI,
bladder
outlet
AKI
or
post-obstructive
diuresis
normal
initially
Urine
Osm
<
serum
Osm
obstruction,
etc)
Serum
Na+
and
Osm
Acromegaly,
post-pituitary
History
(chronic
salt
and
water
retention
normal
resection
Urine
Osm
<
serum
Osm
with
acromegaly)
Serum
Na+
and
Osm
normal
Seen
with
induced
hypertension
(e.g.
Vasoconstrictor
therapy
Urine
Na+
low
treatment
of
vasospasm)
Urine
Osm
variable
Serum
Na+
low
Serum
Osm
low
Typically
occurs
after
SAH
Cerebral
salt
wasting
Urine
Na+
>
50
Intravascular
volume
reduced
Urine
Osm
normal-high
Serum
Na+
normal-low
Serum
Osm
normal-low
Loop
diuretics
Urine
Na+
normal-high
Urine
Osm
not
low
Treatment
of
Other
Causes
of
Polyuria:
Osmotic
Monitor
volume
status;
resolves
once
the
drug
clears
Mannitol
Insulin,
d/c
glucocorticoids,
switch
from
continuous
to
Glucose
intermittent
tube
feeding
Postoperative/postresuscitative
Monitor
fluid
status
and
electrolytes;
resolves
spontaneously
diuresis
Monitor
volume
status
and
electrolytes,
replace
fluids
if
patient
Post-obstructive/AKI
becomes
dehydrated
or
develops
electrolyte
abnormalities
Monitor
volume
status;
resolves
spontaneously
without
Acromegaly
electrolyte
imbalance
Vasoconstrictor
therapy
Monitor
fluid
status,
discontinue/reduce
pressors
if
possible
Cerebral
salt
wasting
Fludrocortisone
0.1-0.3
po/pft
bid